Detection of serum slL-2R, IL-6, IL-8,TNF-α and lymphocytes subsets, mIL-2R in patients with chronic hepatitis B
Ping Jiu,Hong Xin,Zhu Yong,Lian Ai,Qi Jian,Sheng Zhan,Mei Yu
DOI: https://doi.org/10.3969/j.issn.1009-3079.2000.07.010
2000-01-01
World Chinese Journal of Digestology
Abstract:AIM: To investigate the expression of mIL-2R and T-cell subset, and changes of sIL-2R, IL-6, IL-8, TNF-α in patients with chronic hepatitis B. METHODS: APAAP and ELISA techniques were used to detect the levels of mIL-2R and T-cell subset in peripheral blood and serum sIL-2R, IL-6, IL-8 and TNF-α in 92 patients with chronic hepatitis B. RESULTS: The count of CD8 + cell was lower whereas the count of CD8 + cell in patients was higher than that in normal control group (P<0.05). The count of CD4 + cell in control and chronic hepatitis B groups (mild chronic hepatitis, moderate to severe chronic hepatitis, post-hepatitis cirrhosis, fulminate hepatitis) were: (45.6±3.6)%, (39.7±10.2)% and (40.6± 11.0)%, (39.0+6.5)% and (31.2±8.9.)%. The count of CD8 + cell in control and chronic hepatitis B groups were: (28.7±3.2)%, (35.4±9.5)%, (38.7±7.6)% and (42.2±9.4)%. The level of mIL-2R was significantly decreased in patients and increased to normal level after PHA simulation. The expression ratio of mIL-2R before PHA simulation in control and chronic hepatitis B groups were: (15.69±4.32)%, (3.98±5.36)%, (9.37±5.48)%, (9.77 ± 5.76) % and (9.58 ±5.45)%. After PHA simulation in control and chronic hepatitis B groups were: (69.82 ± 5.36)%, (67.98 ± 3.69)%, (69.11±2.19)%,(63.93±1.32)% and (66.32 ± 5.26)%. However, the level of sIL-2R, IL-6, IL-8 and TNF-α were increased significantly in patients (P<0.01). The level of TNF-α, IL-6 and IL-8 in serum of moderate to severe chronic hepatitis were: (798.9±69.0)ng/L, (2806.2±211.7)ng/L, (480.6±32.4) ng/L, and <100 ng/L in control group. There was significant difference Of TNF-α, IL-6 and IL-8 between cirrhosis active and stable phase patients, and liver necrosis and recovery phase severe hepatitis. CONCLUSION: Immunoregulation abnormality existed in patients with chronic hepatitis B, which was partly related to cellular factors.